Induction Chemotherapy for Locally Advanced Esophageal Cancer
Status:
Active, not recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy as induction
treatment prior to standard neoadjuvant chemoradiation to decrease the rate of distant
recurrence among patients with locally advanced esophageal cancer.